Volume 43, Issue 11 pp. 1045-1049
Case Report

ETV6 rearrangement in a case of mammary analogue secretory carcinoma of the skin

Michael D Chang

Michael D Chang

Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL, USA

Search for more papers by this author
Allison K Arthur

Allison K Arthur

Sand Lake Dermatology Center, Orlando, FL, USA

Search for more papers by this author
Joaquín J García

Joaquín J García

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

Search for more papers by this author
William R Sukov

William R Sukov

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

Search for more papers by this author
Wonwoo Shon

Corresponding Author

Wonwoo Shon

Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL, USA

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA

Wonwoo Shon, DO,

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA

Tel: 310-423-6623

Fax: 310-426-0122

e-mail: [email protected]

Search for more papers by this author
First published: 10 August 2016
Citations: 15

Abstract

Mammary analog secretory carcinoma of salivary glands is a relatively recently recognized entity that harbors the ETV6-NTRK3 fusion transcript. To date, only rare cases of mammary analog secretory carcinoma of the skin have been reported. A 57-year-old man presented with a 6.0 cm cystic mass in the axilla, involving the dermis and superficial subcutis. Microscopically, the tumor exhibited nodular aggregation of tubular and microcystic structures embedded in the dense fibrotic and hyalinized stroma. Characteristic ‘colloid-like’ eosinophilic secretory material was present within intraluminal spaces. Tumor cells were largely characterized by vesicular nuclei with inconspicuous nucleoli and pink vacuolated cytoplasm. With respect to immunohistochemistry, tumor cells were intensely positive for AE1/AE3, Cam 5.2, and CK7, whereas Ber-EP4 and CEA were completely negative. A dual color break-apart fluorescence in situ hybridization probe identified rearrangement of the ETV6 gene locus on chromosome 12. The patient is alive with no evidence of recurrent disease or metastasis 3 years after the initial surgery. In conclusion, we report a rare example of mammary analog secretory carcinoma of the skin with ETV6 rearrangement. Awareness of this unique cutaneous tumor and subsequent reporting of additional cases is necessary for better characterization of its completely clinicopathologic spectrum.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.